Navigation Links
Waters Corporation Receives Market Leadership and Product Innovation Awards
Date:10/22/2007

Frost & Sullivan Recognizes Achievements in Creating New Possibilities for

Science and Business

MILFORD, Mass., Oct. 22 /PRNewswire-FirstCall/-- Waters Corporation (NYSE: WAT) today announced that it has been awarded the 2007 Market Leadership Award and the 2007 Product Innovation Award by Frost & Sullivan. The Market Leadership award is in recognition of the Company's success and leadership in liquid chromatography (LC) and acknowledges the results that Waters technologies are having on business performance and on the advancement of science. The Product Innovation Award recognizes the Company's ability to take analytical science to the next level specifically with its laboratory informatics software portfolio and information management platforms.

"Having achieved leadership status in both segments of the U.S. liquid chromatography market, Waters is therefore a complete solutions provider for users employing liquid chromatography as a separations methodology," says Frost & Sullivan Research Analyst Shankar Sellappan, Ph.D. "Moreover, with additional uses and applications being developed for this technology, the company is set to benefit significantly in the future."

"In addition to designing, manufacturing and distributing UltraPerformance LC(R)(UPLC(R)), high performance liquid chromatography (HPLC) and mass spectrometry (MS) instrument systems and associated service and support products, Waters has also become a leading developer and supplier of software- based solutions," notes Frost & Sullivan Research Analyst Dr. Amarpreet Dhiman. "Frost & Sullivan believes that Waters is well placed to develop innovative, business critical software and versatile workflow management solutions by leveraging its leading position in existing markets."

"Receiving this recognition from Frost & Sullivan, is especially gratifying because it confirms our commitment to the success of the laboratory and the organizations that depend on them," said Rohit Khanna, Ph.D., Vice President of Worldwide Marketing, Waters Division. "Our informatics portfolio brings insight and decision-making power to scientific discovery and effective business management and continues to be the preferred choice for industry- leading companies."

About Frost & Sullivan

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit http://www.awards.frost.com.

About Waters Corporation (http://www.waters.com)

Waters Corporation (NYSE: WAT) creates business advantage for laboratory- dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, supported by an expert customer services team, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.28 billion in 2006 and 4,700 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Media Contacts:

Brian J. Murphy

Public Relations

Waters Corporation

508-482-2614

Brian_J_Murphy@waters.com


'/>"/>
SOURCE Waters Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Indian Ayurveda in troubled waters abroad.
2. Swimming in Troubled Waters
3. DDT Still Present In The Waters Of Los Angeles County
4. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
5. Infant receives first bloodless liver transplant
6. British MPs Say Prostate Cancer Receives Low Priority in the NHS
7. Fifth US Patient Receives Artificial Heart
8. Northfield Labs Receives FDA Comments
9. Abbott Receives CE Mark Certification
10. Zactima Receives Fast Track Designation By The FDA
11. East London Receives World Class New Private Hospital Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... TX (PRWEB) , ... February 23, 2017 , ... ... announced an official 2017 partnership with The Jensie Gran Fondo of Marin. For ... and UVB rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to ...
(Date:2/23/2017)... ... 2017 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... Beach to host its Swirl: Miami Wine Tasting Event on March 28, 2017. ...
(Date:2/23/2017)... Los Angeles, CA (PRWEB) , ... February 23, 2017 , ... ... the first two episodes of WE TV’s “Mama June: From Not to Hot,” which ... of TV notable, “Mama” June Shannon, known to millions from the 2012 reality television ...
(Date:2/23/2017)... ... 23, 2017 , ... EBSCO Information Services (EBSCO) ... for Health and Care Excellence (NICE) framework. The agreement allows purchasers from ... to search, order and purchase medical and healthcare-related content through GOBI ®, ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... new, interactive publication where generations converge and explore the world from different perspectives. ... Dialog Magazine enables readers to gain understanding, increase empathy, and find greater happiness. ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 /PRNewswire/ ... USD 330.6 million by 2021 from USD 275.9 ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... industries, increasing spending on pharmaceutical R&D, and growth ... factors driving the market growth for particle counters. ...
(Date:2/24/2017)... Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology ... it has acquired exclusive worldwide rights to develop, ... HDAC inhibitor targeting hematological and solid tumors. ... 1 and 2 clinical trials of Abexinostat in ... have already been completed, demonstrating that Abexinostat is ...
(Date:2/23/2017)... BOSTON , Feb. 23, 2017 ... devices and services since 1997, is changing the ... modern technology providing patients with pro-active, custom-made solutions. ... desire for instant and affordable healthcare without walls, ... of high-level devices developed with healthcare professionals that ...
Breaking Medicine Technology: